Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Clinical Characteristics and Treatment Allocations in Patients with Myelodysplastic Syndromes and Monosomy 7: Results from an International Multicenter Study Suggest That Hypomethylating Agents Significantly Improve Overall- and AML-Free Survival in Patients Classified As Very High Risk By IPSS-R

Julie Schanz, MD PhD, Friederike Braulke, MD, Ghulam J. Mufti, MD PhD, Elena Crisà, Austin Kulasekararaj, Kathrin Nachtkamp, MD, Ulrich Germing, Stefan Schmitz, MD PhD, Peter Haas, MD, Michael Lübbert, Catharina Müller-Thomas, MD, Katharina Götze, Uwe Platzbecker, MD, Florian Nolte, Wolf-Karsten Hofmann, MD PhD, Detlef Haase

Blood (2014) 124 (21): 4656.

https://doi.org/10.1182/blood.V124.21.4656.4656

Published: 2014

Journal Articles

Detection of Karyotype Evolution From Peripheral Blood by Sequential FISH Analyses of Circulating CD34+ Cells In MDS Patients: Results of the Ongoing German Multicenter Prospective Diagnostic Study

Friederike Braulke, MD, Julie Schanz, MD, Michael Metz, MD, Sven Detken, MD, Joerg Seraphin, MD, Katharina Götze, MD, Catharina Mueller-Thomas, MD, Uwe Platzbecker, MD, Tim Henrik Brümmendorf, MD, Aristoteles A.N. Giagounidis, MD, Ulrich Germing, MD, Kathleen Jentsch-Ullrich, MD, Angelika Boehme, MD, Gesine Bug, MD, Oliver G. Ottmann, Prof, Dr., med., Philippe Schafhausen, MD, Lorenz Trümper, MD, Detlef Haase, MD

Blood (2010) 116 (21): 2937.

https://doi.org/10.1182/blood.V116.21.2937.2937

Published: 2010

Journal Articles

Evidence for a Suppression of the Colony Forming Capacity of Erythroid Progenitors by Iron Overload in Patients with MDS

Julia Hartmann, Ursula Sinzig, Gerald Wulf, MD, PhD, Lorenz H. Truemper, MD, PhD, Friederike Braulke, MD, Frank Konietschke, Detlef Haase, MD, PhD

Blood (2008) 112 (11): 2694.

https://doi.org/10.1182/blood.V112.11.2694.2694

Published: 2008

Journal Articles

Analysing Circulating CD34+ Cells by FISH Is Representative for the Clone Size in Bone Marrow in MDS Patients Under Different Therapy Modalities

Friederike Braulke, MD, Julie Schanz, MD, Lorenz H. Truemper, MD, PhD, Detlef Haase, MD, PhD

Blood (2008) 112 (11): 2696.

https://doi.org/10.1182/blood.V112.11.2696.2696

Published: 2008

Journal Articles

FISH-Analyses of Cirulating CD34+ Cells in MDS-Patients - A Suitable Method To Measure and Predict Response to 5-Azacytidine.

Friederike Braulke, MD, Julie Schanz, MD, Christian Steidl, MD, Lorenz H. Truemper, PhD, MD, Detlef Haase, PhD, MD

Blood (2007) 110 (11): 2466.

https://doi.org/10.1182/blood.V110.11.2466.2466

Published: 2007

NARROW

Clinical Characteristics and Treatment Allocations in Patients with Myelodysplastic Syndromes and Monosomy 7: Results from an International Multicenter Study Suggest That Hypomethylating Agents Significantly Improve Overall- and AML-Free Survival in Patients Classified As Very High Risk By IPSS-R

Detection of Karyotype Evolution From Peripheral Blood by Sequential FISH Analyses of Circulating CD34+ Cells In MDS Patients: Results of the Ongoing German Multicenter Prospective Diagnostic Study

Evidence for a Suppression of the Colony Forming Capacity of Erythroid Progenitors by Iron Overload in Patients with MDS

Analysing Circulating CD34+ Cells by FISH Is Representative for the Clone Size in Bone Marrow in MDS Patients Under Different Therapy Modalities

FISH-Analyses of Cirulating CD34+ Cells in MDS-Patients - A Suitable Method To Measure and Predict Response to 5-Azacytidine.

Email alerts

ASH Publications

American Society of Hematology

Clinical Characteristics and Treatment Allocations in Patients with Myelodysplastic Syndromes and Monosomy 7: Results from an International Multicenter Study Suggest That Hypomethylating Agents Significantly Improve Overall- and AML-Free Survival in Patients Classified As Very High Risk By IPSS-R

Detection of Karyotype Evolution From Peripheral Blood by Sequential FISH Analyses of Circulating CD34+ Cells In MDS Patients: Results of the Ongoing German Multicenter Prospective Diagnostic Study

Evidence for a Suppression of the Colony Forming Capacity of Erythroid Progenitors by Iron Overload in Patients with MDS

Analysing Circulating CD34+ Cells by FISH Is Representative for the Clone Size in Bone Marrow in MDS Patients Under Different Therapy Modalities

FISH-Analyses of Cirulating CD34+ Cells in MDS-Patients - A Suitable Method To Measure and Predict Response to 5-Azacytidine.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only